CCaTS: Accelerating discoveries toward better health
Mayo Clinic Center for Clinical and Translational Science (CCaTS) is a central hub for institutional advancement of research and education at Mayo Clinic. The center provides tools and expert consultation to support every aspect of medical research, including basic discovery science, clinical and community-engaged research, and late-stage application and commercialization.
CCaTS is led by Claudia Lucchinetti, M.D., principal investigator and director of CCaTS and dean for clinical and translational science at Mayo Clinic. David O. Warner, M.D., is co-principal investigator and associate director of CCaTS, and is also principal investigator of the KL2 mentored career development grant. Anthony J. Windebank, M.D., is principal investigator of the TL1 predoctoral training grant.
News
Mayo Clinic launches COVID-19 Vaccine research registry
Mayo Clinic has launched a COVID-19 Vaccine Registry that will identify people interested in participating in upcoming COVID-19 vaccine clinical trials. People who add their name to the registry may be contacted in the future to determine if they are eligible to participate in a COVID-19 vaccine trial at Mayo Clinic.
Read more on the Mayo Clinic News Network.
New research shows markers in donor kidneys that could reduce risks
A new study of living kidney donors at Mayo Clinic in Minnesota and Arizona from 1999 to 2018 has found some microstructural features that can indicate some long-term susceptibility for chronic kidney disease in otherwise healthy adults.
Read more on Mayo's Advancing the Science blog.
Faced with a pandemic, undergrad Research programs innovate
Disruptions due to COVID-19 didn't deter undergraduates committed to a summer of research training at Mayo Clinic. Instead, they learned to thrive in a virtual environment and even presented their scientific posters online.
Read more on Mayo's Advancing the Science blog.
Needed: A national coalition to coordinate covid-19 clinical trials
Leaders from Mayo Clinic and Cleveland Clinic came together to pen an op-ed calling for the formation of a national, nonprofit clinical trials coalition. To goal is to ensure that COVID-19 research leads to rigorous, generalizable, and definitive results, and to set the stage for future research priorities with the greatest impact.
Read more on STAT.
High-RISK Minnesotans ID'd for COVID-19 prevention
Racial and ethnic disparities have been widely observed in COVID-19 infection and outcomes. In this article, Mark Wieland, M.D., a Mayo health disparities researcher, talks about how these disparities are connected to social determinants of health.
Read more in the Star Tribune.